N/A N=28 Access-H20 Faucet for Spinal Cord Injury
Spinal Cord Injury Cervical
Primary: Water Access for Activities of Daily Living — 18; 10; 0; 0 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=23 sEphB4-HSA in Treating Patients With Kaposi Sarcoma
Skin Kaposi Sarcoma
Primary: Proportion of Participants Experiencing Clinical Response — 56.5 percentage of participants
N/A N=80 Reducing Burden in Care Partners of Community-Dwelling Persons With Dementia and Oropharyngeal Dysphagia
Caregiver Burden · Alzheimer Disease · Dementia
Primary: Mean Care Partner Burden at 3 Months Post Hospital Discharge — 41.3; 42.8 ZBI Score
N/A N=25 Harm Reduction Strategies for Gay, Bisexual and Other Men Who Have Sex With Men Engaging in Chemsex
Harm Reduction
Primary: Usability of the App — 2.14 Scores on the MAUQ
Phase 3 N=39 High-protein Oral Supplement With Liposomal Curcumin in Adults Undergoing Hemodialysis.
Chronic Kidney Disease 5D
Primary: High-sensitivity C-reactive Protein — 11.16; 11.84 milligrams per liter (mg/L) — p=0.004
N/A N=366 Diabetes Disparities: Texting to Extend Treatment (DD-TXT)
Diabetes Mellitus, Type 2
Primary: Change in HbA1c Percent Time in Control — 23.41; 21.61 percent (%) of time in control — p=.6519
N/A N=498 Diagnostic Accuracy of WEARable TECHnology Single-lead ECG in Detecting Cardiac Arrhythmias
Cardiac Arrhythmia · Atrial Fibrillation
Primary: Compare the Diagnostic Performance of Physician Rhythm Interpretation of 1-lead ECG Generated by SkyLabs CART-I Ring and Apple Watch Versus 12-lead ECG (Gold-standard)…
Phase 2 N=227 A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis
Plaque Psoriasis
Primary: Percentage of Participants Who Achieved Greater Than or Equal to (>=) 75 Percent (%) Improvement From Baseline in Psoriasis Area Severity Index Score (PASI-75) at LTE…
Phase 2 N=124 Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)
Metabolic Dysfunction-Associated Steatotic Liver Disease · Non-alcoholic Fatty Liver Disease · Nonalcoholic Fatty Liver Disease
Primary: Mean Relative Reduction From Baseline in Liver Fat Content at Week 28 — 67.8; 54.4; 42.1 Percent Reduction
Phase 2 N=40 Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects
Obesity; Overweight
Primary: Food Consumption — 605.5; 404.3; 423.6 weight food eaten g
Phase 1 N=16 Comparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid Tablets
Healthy
Primary: Cmax of Aramchol — 3.334; 2.057; 0.668 µg/mL
Phase 2 N=63 Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
PDAC - Pancreatic Ductal Adenocarcinoma · FAP
Primary: Sensitivity of [68Ga]FAPI-46 PET Imaging to Detect PDAC, Using Histopathology as Truth Standard — 0.741 proportion of participants
Phase 2 N=21 Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis
Gynecologic Cancer · Gynecologic Neoplasms · Peritoneal Carcinomatosis
Primary: Proportion of Participants Who Are Successfully Down Staged to Resectable Based on Peritoneal Carcinomatosis Index (PCI) and Principal Investigator (PI) Discretion…
N/A N=300 Treatment, Pain, and Opioids
Chronic Pain
Primary: Medical Record Review and Treatment Utilization Form — 19; 17 Participants — p=.6469
N/A N=15 Comparing Powered Ported Bone Marrow Aspiration to Manual Standard Bone Marrow Aspiration Procedures
Healthy
Primary: Quality of Aspirate Specimen Yield Total Score -Jamshidi Manual Standard Device — 4.83; 5.75; 1.5; 1.5 units on a scale